<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02748941</url>
  </required_header>
  <id_info>
    <org_study_id>69HCL15_0458</org_study_id>
    <nct_id>NCT02748941</nct_id>
  </id_info>
  <brief_title>Carotid Atherosclerosis : Innovative Imaging Biomarkers. Study Case-control</brief_title>
  <acronym>ACABII</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>Hospices Civils de Lyon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Fondation de France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Bracco Imaging S.p.A.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Hospices Civils de Lyon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Cerebrovascular accident (CVA) constitutes a major health public problem. This represents the&#xD;
      second cardiovascular death cause. CVA is ischemic in 80% of cases. Atheroma of large&#xD;
      arteries, mainly carotid, is involved in about 20% of cases.&#xD;
&#xD;
      After several high grade studies (NASCET, ECST, ACAS, ACST), carotid surgery is based on&#xD;
      stenosis calculation by Doppler ultrasound, CT angiography, MRI angiography or arteriography.&#xD;
&#xD;
      The composition of the plaque, showing its vulnerability, is associated with embolic risk and&#xD;
      stroke. The therapeutic strategy based only on the narrowing of the arterial lumen is not&#xD;
      satisfactory enough to prevent the occurrence of a transient ischemic attack (TIA) or an&#xD;
      ipsilateral stroke due to carotid stenosis. Thus, new techniques emerge, to evaluate in vivo&#xD;
      the inflammation of the plaque, its embolic consequences or the mechanical stress it&#xD;
      undergoes. These techniques are: High Resolution MRI (HR MRI), evaluation of the Gray Scale&#xD;
      Median (GSM) level, study of the plaque vascularization with Contrast Enhanced ultrasound&#xD;
      (CEUS), High Intensity Transient Signals (HITS) by transcranial Doppler, micro RNA profile&#xD;
      (mi RNA). These different modalities must be combined in order to increase the efficiency.&#xD;
&#xD;
      Based on these encouraging results, the investigator aim at evaluating the ability of&#xD;
      different methods or their combination to predict the occurrence of ischemic stroke or TIA&#xD;
      due to emboli from a carotid atherosclerotic plaque. Before considering a cohort study, he&#xD;
      investigator want to evaluate the performance of each of these new methods in the&#xD;
      characterization of carotid plaque instability. Performance evaluation will allow us to&#xD;
      choose secondarily the most relevant association.&#xD;
&#xD;
      The investigator propose, as a first step, to make a case-control study with these methods,&#xD;
      the cases are patients who had an ischemic stroke (authenticated by both the clinical exam&#xD;
      and brain MRI) on the same side as the carotid stenosis and the controls are patients with&#xD;
      carotid stenosis but without ischemic stroke. This study is a cross-sectional study because&#xD;
      it simultaneously measures the occurrence of the event (ischemic stroke) and the&#xD;
      characteristics of the atheromatous plaque.&#xD;
&#xD;
      Over a 2 year period, 45 symptomatic patients and 105 asymptomatic patients will be included&#xD;
      with a carotid stenosis with at least a 50% caliber constriction according to NASCET&#xD;
      criteria. (North American Symptomatic Carotid Endarterectomy Trial).&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 12, 2017</start_date>
  <completion_date type="Anticipated">February 12, 2022</completion_date>
  <primary_completion_date type="Anticipated">February 12, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of HITS per hour in doppler ultrasonography</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Ulceration &gt; 2 mm presence in doppler ultrasonography</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>GSM (Gray Scale Median) quantification in doppler ultrasonography</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>CEUS (Contrast Enhanced UltraSound )</measure>
    <time_frame>Day 1</time_frame>
    <description>signal intensity amplification quantification and Ulceration &gt; 2 mm</description>
  </primary_outcome>
  <primary_outcome>
    <measure>hemorrhage intra-plaque présence in HR MRI</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>large lipid-rich necrotic core présence in HR MRI</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>ulceration or cap rupture présence in HR MRI</measure>
    <time_frame>Day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>hemorrhage intra-plaque</measure>
    <time_frame>Day 1</time_frame>
    <description>Compare the results of each modality for pathological analysis of the surgical equipment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>large lipid-rich necrotic core</measure>
    <time_frame>Day 1</time_frame>
    <description>Compare the results of each modality for pathological analysis of the surgical equipment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ulceration or cap rupture</measure>
    <time_frame>Day 1</time_frame>
    <description>Compare the results of each modality for pathological analysis of the surgical equipment.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>shear stresses (Pa) on the surface of the plaque</measure>
    <time_frame>Day 1</time_frame>
    <description>Quantification of the shear stresses (Pa) on the surface of the plaque with an analysis of hemodynamic environment using fluid dynamics mathematical models based on data collected by MRI.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>mi-RNA identification</measure>
    <time_frame>Day 1</time_frame>
    <description>Identification of circulating mi-RNA specific to unstable atherosclerotic plaque by RT-PCR and comparison between case and control</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">77</enrollment>
  <condition>Carotid Stenosis</condition>
  <arm_group>
    <arm_group_label>symptomatic and asymptomatic patients</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>HITS quantification, Ultrasound examinations, High Resolution MRI</intervention_name>
    <description>Simultaneously measure the occurrence of the event (ischemic stroke) and the characteristics of the atheromatous plaque&#xD;
Description of different modalities:&#xD;
HITS quantification&#xD;
Ultrasound examinations:&#xD;
Ulceration &gt;2 mm&#xD;
Plaque thickness&#xD;
GSM: computer analysis after normalization of most informative longitudinal view (image with maximum plaque area) using Photoshop&#xD;
CEUS: plaque vascularization detection after bolus injection of SONOVUE on a video recording from the injection of the contrast (Vuebox - Bracco imaging)&#xD;
High Resolution MRI:&#xD;
Stenosis severity, intraplaque hemorrhage, large lipid-rich necrotic core, ulceration or cap rupture and Brain MRI will be evaluated&#xD;
Quantification of shear stresses (Pa) on the surface of the plaque&#xD;
mi-RNA identification and quantification</description>
    <arm_group_label>symptomatic and asymptomatic patients</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Carotid stenosis ≥ 50% NASCET&#xD;
&#xD;
          -  Case: ipsilateral carotid stenosis stroke, certified by MRI or CT in the preceding&#xD;
             month, with no others causes of stroke&#xD;
&#xD;
          -  Control: no clinical sign or MRI hint for a recent stroke&#xD;
&#xD;
          -  Signed informed consent form&#xD;
&#xD;
          -  Patient affiliated to a social security system or equivalent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Modified Rankin scale &gt; 3&#xD;
&#xD;
          -  Homolateral stroke or TIA &gt; 1 month&#xD;
&#xD;
          -  Medical history of homolateral carotid surgery, cervical radiation, carotid occlusive,&#xD;
             homolateral intracranial stenosis, risk of developing arterial thromboembolic events&#xD;
&#xD;
          -  Renal failure (creatinine clearance &lt; 50 ml/min)&#xD;
&#xD;
          -  Contraindication to ultrasound (sonovue)&#xD;
&#xD;
          -  Contraindication to MRI and its contrast media (Gadolinium)&#xD;
&#xD;
          -  Inability to sign informed consent&#xD;
&#xD;
          -  Inability to undergo any of the technics (claustrophobia…)&#xD;
&#xD;
          -  Serious co-morbid disease, dementia&#xD;
&#xD;
          -  Neurological disease with no carotid disease&#xD;
&#xD;
          -  Risk of pregnancy or pregnancy or breastfeeding&#xD;
&#xD;
          -  Adult under reinforced guardianship or legal guardian&#xD;
&#xD;
          -  Patient not understanding French&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Philippe DOUEK, MD</last_name>
    <phone>(0)472357233</phone>
    <phone_ext>+33</phone_ext>
    <email>philippe.douek@chu-lyon.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Adeline MANSUY, CRA</last_name>
    <phone>(0)4 72 11 5225</phone>
    <phone_ext>+33</phone_ext>
    <email>adeline.mansuy@chu-lyon.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospices Civils de Lyon - Service de radiologie</name>
      <address>
        <city>Bron</city>
        <zip>69500</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Philippe DOUEK, MD</last_name>
      <phone>0472357233</phone>
      <phone_ext>+33</phone_ext>
      <email>philippe.douek@chu-lyon.fr</email>
    </contact>
    <contact_backup>
      <last_name>Adeline MANSUY</last_name>
      <phone>4 72 11 52 25</phone>
      <phone_ext>+33</phone_ext>
      <email>adeline.mansuy@chu-lyon.fr</email>
    </contact_backup>
    <investigator>
      <last_name>Stéphane Luong, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Laura MECHTOUFF, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>February 2021</verification_date>
  <study_first_submitted>April 11, 2016</study_first_submitted>
  <study_first_submitted_qc>April 19, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 22, 2016</study_first_posted>
  <last_update_submitted>February 23, 2021</last_update_submitted>
  <last_update_submitted_qc>February 23, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">February 25, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>unstable/stable atherosclerotic plaque</keyword>
  <keyword>HITS</keyword>
  <keyword>GSM</keyword>
  <keyword>CEUS</keyword>
  <keyword>HR MRI</keyword>
  <keyword>mi-RNA</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Carotid Stenosis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

